Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cui, H.
Right arrow Articles by Feinberg, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cui, H.
Right arrow Articles by Feinberg, A. P.
[Cancer Research 62, 6442-6446, November 15, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Loss of Imprinting in Colorectal Cancer Linked to Hypomethylation of H19 and IGF21

Hengmi Cui, Patrick Onyango, Sheri Brandenburg, Yiqian Wu, Chih-Lin Hsieh and Andrew P. Feinberg2

Institute of Genetic Medicine and Department of Medicine [H. C., P. O., S. B., Y. W., A. P. F.], and Departments of Molecular Biology and Genetics, and Oncology Center [A. P. F.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and Departments of Urology and Biochemistry and Molecular Biology, University of Southern California School of Medicine, Los Angeles, California 90033 [C-L. H.]

Epigenetic alterations in human cancers include global DNA hypomethylation,gene hypomethylation and promoter hypermethylation, and loss of imprinting (LOI) of the insulin-like growth factor-II gene (IGF2). A mechanism for LOI described previously is hypermethylation of a differentially methylated region (DMR) upstream of the H19 gene, allowing activation of the normally silent maternal allele of IGF2. Here we show that this mechanism does not apply to colorectal cancers, which show hypomethylation of the H19 DMR as well as a DMR upstream of exon 3 of IGF2. This hypomethylation is found in both colorectal cancers and normal mucosa from the same patients, and in cell lines with somatic cell knockout of DNA methyltransferases DNMT1 and DNMT3B. These data suggest that hypomethylation is a mechanism for LOI, that the popular IGF2-H19 enhancer competition model for IGF2 imprinting does not apply to the human colon, and that an alternative model for LOI would involve a transcriptional repressor acting on the normally silent maternal allele of IGF2.




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Nguyen, H. Cui, K. S. Bisht, L. Sun, K. Patel, R. S. Lee, H. Kugoh, M. Oshimura, A. P. Feinberg, and D. Gius
CTCFL/BORIS Is a Methylation-Independent DNA-Binding Protein That Preferentially Binds to the Paternal H19 Differentially Methylated Region
Cancer Res., July 15, 2008; 68(14): 5546 - 5551.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Qiu, T. H. Vu, Q. Lu, J. Q. Ling, T. Li, A. Hou, S. K. Wang, H. L. Chen, J. F. Hu, and A. R. Hoffman
A Complex Deoxyribonucleic Acid Looping Configuration Associated with the Silencing of the Maternal Igf2 Allele
Mol. Endocrinol., June 1, 2008; 22(6): 1476 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
V. Dighe, L. Clepper, D. Pedersen, J. Byrne, B. Ferguson, S. Gokhale, M. C. T. Penedo, D. Wolf, and S. Mitalipov
Heterozygous Embryonic Stem Cell Lines Derived from Nonhuman Primate Parthenotes
Stem Cells, March 1, 2008; 26(3): 756 - 766.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-M. Byun, H.-L. Wong, E. A. Birnstein, E. M. Wolff, G. Liang, and A. S. Yang
Examination of IGF2 and H19 Loss of Imprinting in Bladder Cancer
Cancer Res., November 15, 2007; 67(22): 10753 - 10758.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. J. Rugg-Gunn, A. C. Ferguson-Smith, and R. A. Pedersen
Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines
Hum. Mol. Genet., October 15, 2007; 16(R2): R243 - R251.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Mitalipov, L. Clepper, H. Sritanaudomchai, A. Fujimoto, and D. Wolf
Methylation Status of Imprinting Centers for H19/IGF2 and SNURF/SNRPN in Primate Embryonic Stem Cells
Stem Cells, March 1, 2007; 25(3): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J J L Wong, N J Hawkins, and R L Ward
Colorectal cancer: a model for epigenetic tumorigenesis
Gut, January 1, 2007; 56(1): 140 - 148.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Tost, H. Jammes, J.-M. Dupont, C. Buffat, B. Robert, T.-M. Mignot, F. Mondon, B. Carbonne, U. Simeoni, G. Grange, et al.
Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region
Nucleic Acids Res., November 14, 2006; 34(19): 5438 - 5448.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. R. Wasson, A. P. McGlynn, H. McNulty, S. L. O'Reilly, V. J. McKelvey-Martin, G. McKerr, J. J. Strain, J. Scott, and C. S. Downes
Global DNA and p53 Region-Specific Hypomethylation in Human Colonic Cells Is Induced by Folate Depletion and Reversed by Folate Supplementation
J. Nutr., November 1, 2006; 136(11): 2748 - 2753.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Egger, S. Jeong, S. G. Escobar, C. C. Cortez, T. W. H. Li, Y. Saito, C. B. Yoo, P. A. Jones, and G. Liang
Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival
PNAS, September 19, 2006; 103(38): 14080 - 14085.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. A. Callinan and A. P. Feinberg
The emerging science of epigenomics.
Hum. Mol. Genet., April 15, 2006; 15(suppl_1): R95 - R101.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. K. Murphy, Z. Huang, Y. Wen, M. A. Spillman, R. S. Whitaker, L. R. Simel, T. D. Nichols, J. R. Marks, and A. Berchuck
Frequent IGF2/H19 Domain Epigenetic Alterations and Elevated IGF2 Expression in Epithelial Ovarian Cancer
Mol. Cancer Res., April 1, 2006; 4(4): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. A. Waterland, J.-R. Lin, C. A. Smith, and R. L. Jirtle
Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus
Hum. Mol. Genet., March 1, 2006; 15(5): 705 - 716.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Harper, J. L. Burns, E. J. Foulstone, M. Pignatelli, S. Zaina, and A. B. Hassan
Soluble IGF2 Receptor Rescues ApcMin/+ Intestinal Adenoma Progression Induced by Igf2 Loss of Imprinting
Cancer Res., February 15, 2006; 66(4): 1940 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Zhao, M. Berho, J. Nogueras, D. Sands, E. Weiss, S. Wexner, F. M. Giardiello, and M. Cruz-Correa
Positive Correlation of Insulin-Like Growth Factor-II with Proliferating Cell Index in Patients with Colorectal Neoplasia
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1819 - 1822.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Pufulete, R Al-Ghnaniem, A Khushal, P Appleby, N Harris, S Gout, P W Emery, and T A B Sanders
Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma
Gut, May 1, 2005; 54(5): 648 - 653.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Prawitt, T. Enklaar, B. Gartner-Rupprecht, C. Spangenberg, M. Oswald, E. Lausch, P. Schmidtke, D. Reutzel, S. Fees, R. Lucito, et al.
Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor
PNAS, March 15, 2005; 102(11): 4085 - 4090.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Raghavan, D. M. Lillington, S. Skoulakis, S. Debernardi, T. Chaplin, N. J. Foot, T. A. Lister, and B. D. Young
Genome-Wide Single Nucleotide Polymorphism Analysis Reveals Frequent Partial Uniparental Disomy Due to Somatic Recombination in Acute Myeloid Leukemias
Cancer Res., January 15, 2005; 65(2): 375 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. X. Fu, S. R. Schwarze, M. L. Kenowski, S. LeBlanc, J. Svaren, and D. F. Jarrard
A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells
J. Biol. Chem., December 10, 2004; 279(50): 52218 - 52226.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Wan, Y. Gong, W. Qin, P. Zhang, J. Li, L. Wei, X. Zhou, H. Li, X. Qiu, F. Zhong, et al.
Large-scale cDNA transfection screening for genes related to cancer development and progression
PNAS, November 2, 2004; 101(44): 15724 - 15729.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Woodson, A. Flood, L. Green, J. A. Tangrea, J. Hanson, B. Cash, A. Schatzkin, and P. Schoenfeld
Loss of Insulin-Like Growth Factor-II Imprinting and the Presence of Screen-Detected Colorectal Adenomas in Women
J Natl Cancer Inst, March 3, 2004; 96(5): 407 - 410.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Murrell, S. Heeson, W. N. Cooper, E. Douglas, S. Apostolidou, G. E. Moore, E. R. Maher, and W. Reik
An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype
Hum. Mol. Genet., January 15, 2004; 13(2): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. A. Ulaner, Y. Yang, J.-F. Hu, T. Li, T. H. Vu, and A. R. Hoffman
CTCF Binding at the Insulin-Like Growth Factor-II (IGF2)/H19 Imprinting Control Region Is Insufficient to Regulate IGF2/H19 Expression in Human Tissues
Endocrinology, October 1, 2003; 144(10): 4420 - 4426.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Cui, M. Cruz-Correa, F. M. Giardiello, D. F. Hutcheon, D. R. Kafonek, S. Brandenburg, Y. Wu, X. He, N. R. Powe, and A. P. Feinberg
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Science, March 14, 2003; 299(5613): 1753 - 1755.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Definitions in Epigenetics
Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 321 - 328.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.